Tipton KF - Search Results

1

Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?

O'Brien EM, Tipton KF, Strolin Benedetti M, Bonsignori A, Marrari P, Dostert P. O'Brien EM, et al. Among authors: tipton kf. Biochem Pharmacol. 1991 Jun 1;41(11):1731-7. doi: 10.1016/0006-2952(91)90177-7. Biochem Pharmacol. 1991. PMID: 2043162

2

Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.

O'Brien EM, Dostert P, Tipton KF. O'Brien EM, et al. Among authors: tipton kf. Biochem Pharmacol. 1995 Jul 31;50(3):317-24. doi: 10.1016/0006-2952(95)00145-p. Biochem Pharmacol. 1995. PMID: 7646533

3

Inhibition of monoamine oxidase by clorgyline analogues.

O'Brien EM, Tipton KF, Meroni M, Dostert P. O'Brien EM, et al. Among authors: tipton kf. J Neural Transm Suppl. 1994;41:295-305. doi: 10.1007/978-3-7091-9324-2_39. J Neural Transm Suppl. 1994. PMID: 7931241

4

Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.

O'Brien EM, Dostert P, Pevarello P, Tipton KF. O'Brien EM, et al. Among authors: tipton kf. Biochem Pharmacol. 1994 Aug 30;48(5):905-14. doi: 10.1016/0006-2952(94)90361-1. Biochem Pharmacol. 1994. PMID: 8093103

5

The interactions of milacemide with monoamine oxidase.

O'Brien EM, Tipton KF, McCrodden JM, Youdim MB. O'Brien EM, et al. Among authors: tipton kf. Biochem Pharmacol. 1994 Feb 11;47(4):617-23. doi: 10.1016/0006-2952(94)90123-6. Biochem Pharmacol. 1994. PMID: 8129740

6

A discontinuous luminometric assay for monoamine oxidase.

O'Brien EM, Kiely KA, Tipton KF. O'Brien EM, et al. Among authors: tipton kf. Biochem Pharmacol. 1993 Oct 5;46(7):1301-6. doi: 10.1016/0006-2952(93)90481-b. Biochem Pharmacol. 1993. PMID: 8216383

7

Some peculiar aspects of monoamine oxidase inhibition.

Ramadan ZB, Dostert P, Tipton KF. Ramadan ZB, et al. Among authors: tipton kf. Neurobiology (Bp). 1999;7(2):159-74. Neurobiology (Bp). 1999. PMID: 10591050

8

The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions.

Tipton KF, Fowler CJ, McCrodden JM, Strolin Benedetti M. Tipton KF, et al. Biochem J. 1983 Jan 1;209(1):235-42. doi: 10.1042/bj2090235. Biochem J. 1983. PMID: 6847610 Free PMC article.

9

Developmental aspects of the monoamine-degrading enzyme monoamine oxidase.

Strolin Benedetti M, Dostert P, Tipton KF. Strolin Benedetti M, et al. Among authors: tipton kf. Dev Pharmacol Ther. 1992;18(3-4):191-200. Dev Pharmacol Ther. 1992. PMID: 1306808 Review.

10

Interactions of monoamine oxidase with substrates and inhibitors.

Dostert PL, Strolin Benedetti M, Tipton KF. Dostert PL, et al. Among authors: tipton kf. Med Res Rev. 1989 Jan-Mar;9(1):45-89. doi: 10.1002/med.2610090104. Med Res Rev. 1989. PMID: 2644497 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters